1Vin-Cent Wu,Wen-Je Ko,Hong-Wei Chang,Yung-Wei Chen,Yu-Feng Lin,Chih-Chung Shiao,Yung-Ming Chen,Yih-Sharng Chen,Pi-Ru Tsai,Fu-Chang Hu,Jann-Yuan Wang,Yen-Hung Lin,Kwan-Dun Wu. Risk factors of early redialysis after weaning from postoperative acute renal replacement therapy[J] 2008,Intensive Care Medicine(1):101～108
2Elizabeth Maccariello,Márcio Soares,Carla Valente,Lina Nogueira,Ricardo V. R. Valen?a,José E. S. Machado,Eduardo Rocha. RIFLE classification in patients with acute kidney injury in need of renal replacement therapy[J] 2007,Intensive Care Medicine(4):597～605
3R. Bellomo,Claudio Ronco. Continuous renal replacement therapy in the intensive care unit[J] 1999,Intensive Care Medicine(8):781～789
同被引文献29
1Pastori S, Virzi GM, Brocca A, et al. Cardiorenal syndrome type 1 :a de- fective regulation of monieyte apoptosis induced by proinflammatory and proapoptotic factors E J ]. Cardiorenal Med ,2015,5 ( 2 ) : 105-115.
2Tomiyama H, Yamashina A. Vascular dysfunction : a key player in chron- ic cardiorenal syndrome [ J J. Intern Med ,2015,54 ( 12 ) : 1465-1472.
3Peng DF, Tang SY, Hu Y J, et al. Comparison of valsartan and benazepril when combined with atorcastatin in protecting patients with early cardio- renal syndrome (CRS) [ J ]. Eur Rev Med Pharmacol Sci,2015,19 ( 7 ) : 1264-1271.
